| Dr Muhammed A Hyder, MD | |
|
2465 E Twain Ave, Las Vegas, NV 89121-4011 | |
| (702) 789-6201 | |
| (304) 522-0686 |
| Full Name | Dr Muhammed A Hyder |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 42 Years |
| Location | 2465 E Twain Ave, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013085257 | NPI | - | NPPES |
| 3810002247 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 21858 (West Virginia) | Secondary |
| 2084A0401X | Psychiatry & Neurology - Addiction Medicine | 13930 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Vista Hospital | North las vegas, NV | Hospital |
| Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Henderson Hospital | Henderson, NV | Hospital |
| Entity Name | Behavioral Health Institute Inc (singh) Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205005980 PECOS PAC ID: 0042398984 Enrollment ID: O20080417000584 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Hyder Therapeutic Alliance Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114207503 PECOS PAC ID: 8628241254 Enrollment ID: O20111027000141 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | First Person Care Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659612547 PECOS PAC ID: 2961649207 Enrollment ID: O20130506000286 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Therapeutic Integrated Medical Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770085755 PECOS PAC ID: 4082977764 Enrollment ID: O20180410002890 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Multicultural Counseling Collaborative Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669910543 PECOS PAC ID: 0042562845 Enrollment ID: O20181005000824 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Nevada Mercy And Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457813362 PECOS PAC ID: 5294078861 Enrollment ID: O20190522001892 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Veemed Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477199321 PECOS PAC ID: 0840625836 Enrollment ID: O20200603000923 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Veeone Medical Group Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477199321 PECOS PAC ID: 4385044452 Enrollment ID: O20210611000939 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Veeone Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265156558 PECOS PAC ID: 6800262437 Enrollment ID: O20221115001678 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Entity Name | Veeone Medical Group Ii Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043928443 PECOS PAC ID: 8820468143 Enrollment ID: O20230112002149 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muhammed A Hyder, MD 2248 Via Cadoma, Henderson, NV 89052-7817 Ph: (304) 208-2988 | Dr Muhammed A Hyder, MD 2465 E Twain Ave, Las Vegas, NV 89121-4011 Ph: (702) 789-6201 |
News Archive
Researchers from Emory University's Rollins School of Public Health were awarded a $6.6 million grant from the National Institutes of Health to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
The environment the unborn child is exposed to inside the womb can have a major effect on her or his development and future health. Maternal stress during pregnancy can be transmitted biologically to the unborn child.
The NanoBusiness Alliance today issued a Position Statement on Nanomaterials Product Sustainability, which reflects NanoBusiness Alliance members' enduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.
Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.
› Verified 1 days ago
Dr. Ejine Okoroafor, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5440 W Sahara Ave, Suite 202, Las Vegas, NV 89146 Phone: 914-426-7774 | |
Dr. Garet Jefferson Zaugg, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 300, Las Vegas, NV 89106 Phone: 702-432-2233 Fax: 702-800-5456 | |
Dr. Krista Linn Pinard, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3016 W Charleston Blvd Ste 150, Las Vegas, NV 89102 Phone: 702-790-2701 | |
Gobinder S. Chopra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6410 Medical Center St Ste A100, Las Vegas, NV 89148 Phone: 702-796-8500 Fax: 702-796-8502 | |
Eden Santiago Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3014 W Charleston Blvd Ste 130, Las Vegas, NV 89102 Phone: 702-671-6475 Fax: 702-671-6440 | |
John Reitano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 S Rancho Dr, Ste I62, Las Vegas, NV 89106 Phone: 702-897-7250 Fax: 702-706-4838 |